Home Carboxys 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, 1-(acetyloxy)ethyl ester, (6R,7R)-

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, 1-(acetyloxy)ethyl ester, (6R,7R)-

CAS No.:
64544-07-6
Catalog Number:
AG01CCIP
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%(HPLC)
In Stock USA
United States
$87
- +
25mg
98%(HPLC)
In Stock USA
United States
$223
- +
100mg
98%(HPLC)
In Stock USA
United States
$632
- +
Product Description
Catalog Number:
AG01CCIP
Chemical Name:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, 1-(acetyloxy)ethyl ester, (6R,7R)-
CAS Number:
64544-07-6
MDL Number:
MFCD00864991
IUPAC Name:
1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChI:
InChI=1S/C20H22N4O10S/c1-9(25)33-10(2)34-19(28)15-11(7-32-20(21)29)8-35-18-14(17(27)24(15)18)22-16(26)13(23-30-3)12-5-4-6-31-12/h4-6,10,14,18H,7-8H2,1-3H3,(H2,21,29)(H,22,26)/b23-13-/t10?,14-,18-/m1/s1
InChI Key:
KEJCWVGMRLCZQQ-YJBYXUATSA-N
UNII:
Z49QDT0J8Z
Properties
Complexity:
968  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
1  
Exact Mass:
510.106g/mol
Formal Charge:
0
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
12  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
510.474g/mol
Monoisotopic Mass:
510.106g/mol
Rotatable Bond Count:
12  
Topological Polar Surface Area:
214A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9  
Literature
Title Journal
Thrombotic thrombocytopenic purpura after prophylactic cefuroxime axetil administered in relation to a liposuction procedure. Aesthetic plastic surgery 20120401
A probable association of panic attack with cephuroxime (cefuroxime) axetil administration. Progress in neuro-psychopharmacology & biological psychiatry 20120110
Preformulation studies for direct compression suitability of cefuroxime axetil and paracetamol: a graphical representation using SeDeM diagram. Acta poloniae pharmaceutica 20120101
Cefuroxime-axetil induced allergic angina: an insight into classification management of Kounis syndrome. International journal of cardiology 20110901
Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20110901
Comparative bioavailability study of cefuroxime axetil (equivalent to 500 mg cefuroxime/tablet) tablets (Zednad® versus Zinnat®) in healthy male volunteers. International journal of clinical pharmacology and therapeutics 20110901
Liquid antisolvent preparation of amorphous cefuroxime axetil nanoparticles in a tube-in-tube microchannel reactor. International journal of pharmaceutics 20100816
HPTLC determination of cefuroxime axetil and ornidazole in combined tablet dosage form. Journal of chromatographic science 20100101
Subjective symptoms after treatment of early Lyme disease. The American journal of medicine 20100101
Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects. Arzneimittel-Forschung 20100101
Chiral separation of diastereoisomers of cefuroxime axetil by high-performance thin-layer chromatography. Journal of AOAC International 20100101
Cefuroxime axetil-induced liver failure. Annals of hepatology 20100101
Kounis Syndrome secondary to cefuroxime axetil use in an asthmatic patient. International journal of cardiology 20091112
[Lyme borreliosis: How should erythema migrans be treated in pregnant women?]. Deutsche medizinische Wochenschrift (1946) 20091101
Improvement of psoriasis after antibiotic therapy with cefuroxime axetil. Journal of the European Academy of Dermatology and Venereology : JEADV 20090801
Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability. The Journal of pharmacy and pharmacology 20090601
Synthesis and antibacterial activity of some new 2,3-dimethoxy-3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl)chromanones. European journal of medicinal chemistry 20090401
Infections as complications of neuroleptic malignant syndrome. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101
Antibacterial activities of amorphous cefuroxime axetil ultrafine particles prepared by high gravity antisolvent precipitation (HGAP). Pharmaceutical development and technology 20090101
Simultaneous determination of cefuroxime axetil and ornidazole in tablet dosage form using reversed-phase high performance liquid chromatography. Se pu = Chinese journal of chromatography 20081101
Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080901
[Studies on the action features between cefuroxime axetil and bovine serum albumin]. Guang pu xue yu guang pu fen xi = Guang pu 20080901
Kounis syndrome secondary to cefuroxime-axetil use in an octogenarian. Journal of the American Geriatrics Society 20080901
Dissolution kinetic behavior of drug nanoparticles and their conformity to the diffusion model. Langmuir : the ACS journal of surfaces and colloids 20080715
What is a suitable dissolution method for drug nanoparticles? Pharmaceutical research 20080701
Neurological picture. Horner syndrome due to jugular vein thrombosis (Lemierre syndrome). Journal of neurology, neurosurgery, and psychiatry 20080301
Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old. Aging clinical and experimental research 20080201
Stability of cefuroxime axetil oral suspension at different temperature storage conditions. Bosnian journal of basic medical sciences 20080201
Effect of malnutrition on the pharmacokinetics of cefuroxime axetil in young rats. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20080101
Fatal toxic epidermal necrolysis and severe granulocytopenia following therapy with cefuroxime. Acta dermatovenerologica Croatica : ADC 20080101
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia. Infection 20071201
Nosocomial pneumonia - are economical considerations important? Infection 20071201
Anaphylactic shock associated with cefuroxime axetil: structure-activity relationships. The Annals of pharmacotherapy 20070601
Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimesterof pregnancy? International urogynecology journal and pelvic floor dysfunction 20070501
[Sudden lameness in an afebrile infant]. Anales de pediatria (Barcelona, Spain : 2003) 20070401
Designing a self-associated cationic polymer for enhanced compatibility, palatability, and gastric release of cefuroxime axetil. Biomacromolecules 20070201
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. Scandinavian journal of infectious diseases 20070101
Antabuse reaction with ceftin. The American journal of psychiatry 20061101
Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. International journal of pharmaceutics 20061012
Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20061001
A stability indicating assay method for cefuroxime axetil and its application to analysis of tablets exposed to accelerated stability test conditions. Journal of chromatography. A 20060630
The stability of the amorphous form of cefuroxime axetil in solid state. Journal of pharmaceutical and biomedical analysis 20060607
Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation. AAPS PharmSciTech 20060601
Disappearance of middle ear effusion in acute otitis media monitored daily with tympanometry. Acta paediatrica (Oslo, Norway : 1992) 20060301
Deep neck infection complicating lymphadenitis caused by Streptococcus intermedius in an immunocompetent child. BMC infectious diseases 20060101
Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids. The Journal of pharmacy and pharmacology 20051201
Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent. Southern medical journal 20050901
Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. Acta paediatrica (Oslo, Norway : 1992) 20050901
[Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050901
Treatment of Lyme disease. The Medical letter on drugs and therapeutics 20050523
Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis. The Journal of infection 20050401
Postcoital allergic reaction in a woman. The Journal of emergency medicine 20050201
The stability of Cefuroxime axetil in tablets. Acta poloniae pharmaceutica 20050101
[Pharmacoeconomic analysis of patients with acute exacerbation of chronic bronchitis treated with telithromycin or cefuroxime-axetil]. Revista clinica espanola 20041101
Cholestatic attack due to ampicillin and cross-reactivity to cefuroxime. The Annals of pharmacotherapy 20040901
Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers. International journal of clinical pharmacology and therapeutics 20040701
Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age. Chemotherapy 20040401
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 20040301
Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). Advanced drug delivery reviews 20040223
Investigation of chromatographic conditions for the separation of cefuroxime axetil and its geometric isomer. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040205
Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201
A bioequivalence study of the cefuroxime axetil in healthy volunteers. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20031101
Evaluation of stability of cefuroxime axetil in solid state. Journal of pharmaceutical and biomedical analysis 20030821
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 20030801
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20030401
Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis. Respiratory medicine 20030301
Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis. The Journal of international medical research 20030101
A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis. American journal of rhinology 20030101
[Evaluation of drug sensitivity of the microorganisms isolated from chronic sinusitis treated by beta lactam antibiotics]. Otolaryngologia polska = The Polish otolaryngology 20030101
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis. Clinical therapeutics 20020901
Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 20020601
Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes. International journal of pharmaceutics 20020302
Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis. Medical science monitor : international medical journal of experimental and clinical research 20020101
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA 20011226
Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. The Journal of allergy and clinical immunology 20011001
Evaluation of oral antimicrobial agent levels in tooth extraction sites. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20010601
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010501
Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. The Pediatric infectious disease journal 20010301
Computed tomography imaging of the maxillary and ethmoid sinuses in children with short-duration purulent rhinorrhea. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20010201
Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs 20010101
[Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis]. Vestnik otorinolaringologii 20010101
Bilateral renal cortical necrosis associated with cefuroxime axetil. Clinical nephrology 19980401
Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. The Journal of antimicrobial chemotherapy 19971201
Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 19960701
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. Biochimica et biophysica acta 19940420
Properties